X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11547) 11547
Book Review (2468) 2468
Publication (829) 829
Magazine Article (55) 55
Conference Proceeding (24) 24
Book Chapter (15) 15
Dissertation (11) 11
Book / eBook (4) 4
Paper (3) 3
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10757) 10757
humans (9630) 9630
male (6294) 6294
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (5528) 5528
female (5102) 5102
statins (4781) 4781
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (4085) 4085
middle aged (3996) 3996
aged (3330) 3330
animals (2882) 2882
cholesterol (2428) 2428
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (2400) 2400
risk factors (2156) 2156
cardiac & cardiovascular systems (2143) 2143
pharmacology & pharmacy (2143) 2143
simvastatin (2134) 2134
adult (2029) 2029
treatment outcome (2026) 2026
abridged index medicus (1963) 1963
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (1942) 1942
atorvastatin (1864) 1864
cholesterol, ldl - blood (1486) 1486
atorvastatin calcium (1428) 1428
drug therapy (1255) 1255
rats (1234) 1234
prevention (1233) 1233
risk (1231) 1231
medicine, general & internal (1212) 1212
hypercholesterolemia - drug therapy (1208) 1208
dose-response relationship, drug (1200) 1200
pravastatin (1196) 1196
therapy (1153) 1153
atherosclerosis (1144) 1144
cardiovascular disease (1096) 1096
drug therapy, combination (1091) 1091
peripheral vascular disease (1089) 1089
cardiovascular diseases - prevention & control (1074) 1074
analysis (1037) 1037
lipids (1022) 1022
care and treatment (1003) 1003
time factors (998) 998
dosage and administration (994) 994
statin (985) 985
coronary-heart-disease (977) 977
research (969) 969
hypercholesterolemia (957) 957
cholesterol - blood (938) 938
mortality (920) 920
aged, 80 and over (908) 908
cardiovascular (881) 881
retrospective studies (824) 824
anticholesteremic agents - therapeutic use (806) 806
cardiovascular diseases (801) 801
disease (796) 796
heptanoic acids - administration & dosage (775) 775
antilipemic agents (771) 771
pyrroles - administration & dosage (770) 770
rosuvastatin (763) 763
mice (752) 752
c-reactive protein (738) 738
rosuvastatin calcium (736) 736
prospective studies (735) 735
health aspects (729) 729
inflammation (728) 728
simvastatin - administration & dosage (722) 722
myocardial-infarction (719) 719
cardiovascular-disease (706) 706
cardiology (703) 703
cardiovascular agents (702) 702
medicine & public health (702) 702
double-blind method (695) 695
follow-up studies (694) 694
hydroxymethylglutaryl-coa reductase inhibitors (694) 694
lipids - blood (679) 679
metaanalysis (662) 662
heptanoic acids - therapeutic use (660) 660
pyrroles - therapeutic use (655) 655
simvastatin - therapeutic use (651) 651
coa reductase inhibitors (632) 632
internal medicine (625) 625
drug interactions (621) 621
randomized controlled trials as topic (617) 617
risk assessment (614) 614
anticholesteremic agents - administration & dosage (613) 613
dyslipidemias - drug therapy (607) 607
triglycerides - blood (600) 600
hyperlipidemias - drug therapy (596) 596
low density lipoproteins (591) 591
simvastatin - pharmacology (579) 579
statin therapy (573) 573
lovastatin (568) 568
cholesterol, hdl - blood (567) 567
coronary heart disease (555) 555
diabetes (544) 544
disease models, animal (541) 541
clinical trials (540) 540
safety (538) 538
biomarkers - blood (526) 526
hmg-coa reductase (523) 523
hydroxymethylglutaryl-coa reductase inhibitors - pharmacokinetics (522) 522
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11096) 11096
German (87) 87
Spanish (71) 71
Russian (68) 68
Japanese (53) 53
French (43) 43
Hungarian (33) 33
Italian (29) 29
Polish (19) 19
Chinese (17) 17
Czech (12) 12
Swedish (12) 12
Dutch (11) 11
Norwegian (11) 11
Turkish (9) 9
Ukrainian (9) 9
Danish (7) 7
Finnish (7) 7
Portuguese (5) 5
Hebrew (4) 4
Croatian (3) 3
Lithuanian (1) 1
Romanian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMJ : British Medical Journal, ISSN 0959-8138, 5/2013, Volume 346, Issue 7911, pp. 14 - 14
Objective To examine the risk of new onset diabetes among patients treated with different HMG-CoA reductase inhibitors (statins).Design Population based cohort... 
RESEARCH | Secondary prevention | Depopulation | Population growth | Diabetes | Older adults | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | THERAPY | EVENTS | CHOLESTEROL | CORONARY | DISEASE | PREVENTION | RANDOMIZED CONTROLLED-TRIAL | MELLITUS | ATORVASTATIN | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Simvastatin - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Male | Fluorobenzenes - administration & dosage | Heptanoic Acids - adverse effects | Diabetes Mellitus, Type 2 - epidemiology | Incidence | Dose-Response Relationship, Drug | Pyrroles - administration & dosage | Cardiovascular Diseases - epidemiology | Heptanoic Acids - administration & dosage | Pravastatin - adverse effects | Pyrroles - adverse effects | Diabetes Mellitus, Type 2 - etiology | Female | Retrospective Studies | Odds Ratio | Dyslipidemias - drug therapy | Pyrimidines - administration & dosage | Simvastatin - administration & dosage | Proportional Hazards Models | Rosuvastatin Calcium | Treatment Outcome | Atorvastatin Calcium | Dyslipidemias - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Pravastatin - administration & dosage | Ontario - epidemiology | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Aged | Fluorobenzenes - adverse effects | Diabetes Mellitus, Type 2 - chemically induced | Population Surveillance | Sulfonamides - administration & dosage | Cohort Studies | Inhibitor drugs | Risk assessment | Statins | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
by Fulcher, Jordan and O'Connell, Rachel and Voysey, Merryn and Emberson, Jonathan and Blackwell, Lisa and Mihaylova, Borislava and Simes, John and Collins, Rory and Kirby, Adrienne and Colhoun, Helen and Braunwald, Eugene and La Rosa, John and Pedersen, T.R and Tonkin, Andrew and Davis, Barry and Sleight, Peter and Franzosi, Maria Grazia and Baigent, Colin and Keech, Anthony and De Lemos, J and Braunwald, E and Blazing, M and Murphy, S and Downs, J.R and Gotto, A and Clearfield, M and Holdaas, H and Gordon, D and Davis, B and Koren, M and Dahlöf, B and Poulter, N and Sever, P and Knopp, R.H and Fellström, B and Holdaas, H and Jardine, A and Schmieder, R and Zannad, F and Goldbourt, U and Kaplinsky, E and Colhoun, H.M and Betteridge, D.J and Durrington, P.N and Hitman, G.A and Fuller, J and Neil, A and Wanner, C and Krane, V and Sacks, F and Moyé, L and Pfeffer, M and Hawkins, C.M and Braunwald, E and Kjekshus, J and Wedel, H and Wikstrand, J and Barter, P and Tavazzi, L and Maggioni, A and Marchioli, R and Tognoni, G and Franzosi, M.G and Maggioni, A and Bloomfield, H and Robins, S and Collins, R and Armitage, J and Parish, S and Peto, R and Sleight, P and Pedersen, T.R and Ridker, P.M and Holman, R and Meade, T and Simes, J and MacMahon, S and Marschner, I and Tonkin, A and Shaw, J and Serruys, P.W and Nakamura, H and Knatterud, G and Furberg, C and Byington, R and Macfarlane, P and Cobbe, S and Ford, I and Murphy, M and Blauw, G.J and Packard, C and Shepherd, J and Kjekshus, J and Pedersen, T and Wilhelmsen, L and Braunwald, E and Cannon, C and Murphy, S and Collins, R and Armitage, J and ... and Cholesterol Treatment Trialists' C and Cholesterol Treatment Trialists' (CTT) Collaboration
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9976, pp. 1397 - 1405
Journal Article
JAMA, ISSN 0098-7484, 11/2016, Volume 316, Issue 19, pp. 1997 - 2007
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2021 - 2031
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2012, Volume 125, Issue 9, pp. 882 - 887.e1
Abstract Objective Combination therapy, specifically with aspirin, cholesterol and blood pressure-lowering drugs, substantially reduces the risk of coronary... 
Internal Medicine | Adherence | Prevention | Cardiovascular disease | PERSISTENCE | ACUTE CORONARY SYNDROMES | CONVERTING ENZYME-INHIBITORS | SECONDARY PREVENTION | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | STATIN THERAPY | ACUTE MYOCARDIAL-INFARCTION | BETA-BLOCKERS | MEDICATION ADHERENCE | ARTERY-DISEASE | Drug Costs | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Medication Adherence - statistics & numerical data | Cardiovascular Agents - administration & dosage | Age Factors | Drug Administration Schedule | Cardiovascular Diseases - prevention & control | Humans | Antihypertensive Agents - administration & dosage | Secondary Prevention - methods | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Aspirin - administration & dosage | Drug Prescriptions - statistics & numerical data | Self Administration | Time Factors | Anticholesteremic Agents - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Calcium Channel Blockers - administration & dosage | Primary Prevention - methods | Sodium Chloride Symporter Inhibitors - administration & dosage | Myocardial Infarction - prevention & control | Adrenergic beta-Antagonists - administration & dosage | Angiotensin Receptor Antagonists - administration & dosage | Research | Patient compliance | Coronary heart disease | Disease prevention | Prescription drugs | Drug therapy | Meta-analysis | Index Medicus | Abridged Index Medicus | Drugs | Myocardial infarction | Aspirin | Side effects | Enzyme inhibitors | Risk reduction | Age | Statins
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2016, Volume 374, Issue 21, pp. 2032 - 2043
In a 2-by-2 factorial trial, 12,705 persons at intermediate risk were assigned to candesartan plus hydrochlorothiazide or placebo and to rosuvastatin or... 
STROKE | MORTALITY | TRIALS | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | COUNTRIES | THERAPY | MYOCARDIAL-INFARCTION | STRATEGY | PREVENTION | INTERHEART | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Rosuvastatin Calcium - adverse effects | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Hydrochlorothiazide - administration & dosage | Rosuvastatin Calcium - administration & dosage | Antihypertensive Agents - adverse effects | Medication Adherence | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Benzimidazoles - administration & dosage | Tetrazoles - administration & dosage | Cardiovascular Diseases - epidemiology | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Care and treatment | Usage | Clinical trials | Rosuvastatin | Dosage and administration | Cardiovascular diseases | Risk factors | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Cardiovascular disease | Lipids | Hydrochlorothiazide | Low density lipoprotein | Cholesterol | Disease prevention | Blood pressure | Health risk assessment | Drug therapy | Heart diseases | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 16, pp. 1489 - 1499
Journal Article